CBAY insider trading

CymaBay Therapeutics, Inc.: insider trade history from SEC Form 4 filings.

Total Form 4 trades
212
Last 90 days
0
Buys / sells
19% / 42%
Market cap
—

CBAY insider activity at a glance

FilingIQ tracks 212 insider transactions for CBAY in filings since May 19, 2015. The most recent transaction is dated Mar 22, 2024.

Across the full history, 40 open-market purchases and 90 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on CBAY insider trades is 59.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest CBAY Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Frequently asked

How many insider trades does FilingIQ track for CBAY?
FilingIQ tracks 212 Form 4 insider transactions for CBAY (CymaBay Therapeutics, Inc.), covering filings from May 19, 2015 onwards. 0 of those are dated within the last 90 days.
Are CBAY insiders net buyers or net sellers?
Across the full Form 4 history for CBAY, 40 transactions (19%) were open-market purchases and 90 (42%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does CBAY insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

Methodology & sources

Every CBAY insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.